Instil Bio Inc (TIL)

Jun 03, 2025

Instil Bio appoints new Chief Medical Officer By Investing.com - Investing.com South Africa

Jun 03, 2025

Jun 02, 2025

Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Securities | TIL Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

Instil Bio (TIL) Appoints Jamie Freedman as Chief Medical Officer | TIL Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

Former Genentech Executive With 15 FDA Approvals Joins Instil Bio to Accelerate Cancer Drug Development - Stock Titan

Jun 02, 2025

Jun 02, 2025

Instil Bio shares hold as JMP reiterates Market Perform rating - Investing.com Australia

Jun 02, 2025

Jun 02, 2025

Instil Bio shares hold as JMP reiterates Market Perform rating By Investing.com - Investing.com Canada

Jun 02, 2025

May 31, 2025

Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock? - MSN

May 31, 2025

May 30, 2025

Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade - MSN

May 30, 2025

May 30, 2025

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 30, 2025

May 30, 2025

Instil Bio CEO Reveals Latest Pipeline Updates at Prestigious Jefferies Healthcare Conference - Stock Titan

May 30, 2025

May 28, 2025

Instil Bio Elects Director and Ratifies Auditor - TipRanks

May 28, 2025

May 27, 2025

Instil Bio Advances Phase 2 Trial in China - TipRanks

May 27, 2025

May 26, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025

May 25, 2025

Instil Bio: Second Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF Success (TIL) - Seeking Alpha

May 25, 2025

May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 By Investing.com - Investing.com South Africa

May 24, 2025

May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 - Investing.com

May 24, 2025

May 24, 2025

Instil Bio (TIL) Receives Price Target Upgrade by HC Wainwright & Co. | TIL Stock News - GuruFocus

May 24, 2025

May 24, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following P - GuruFocus

May 24, 2025

May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst - GlobeNewswire

May 23, 2025

May 23, 2025

Instil Bio and ImmuneOnco Announce Joint Investor Breakfast in Chicago to Discuss Immuno-Oncology Developments - Nasdaq

May 23, 2025

May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving ... - Bluefield Daily Telegraph

May 23, 2025

May 23, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following Positive Data Release | TIL Stock News - GuruFocus

May 23, 2025

May 22, 2025

Instil Bio (TIL) Advances Clinical Trials for NSCLC Treatment | - GuruFocus

May 22, 2025

May 22, 2025

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in - GlobeNewswire

May 22, 2025

May 22, 2025

Instil Bio (TIL) Shares Surge on New Clinical Development Plans - GuruFocus

May 22, 2025

May 22, 2025

Instil Bio stock rises on cancer trial updates (TIL:NASDAQ) - Seeking Alpha

May 22, 2025

May 22, 2025

Instil Bio (TIL) Maintains Buy Rating as Price Target is Adjusted | TIL Stock News - GuruFocus

May 22, 2025

May 22, 2025

Instil Bio stock price target cut to $105 by H.C. Wainwright - Investing.com Nigeria

May 22, 2025

May 22, 2025

Instil Bio (TIL) Price Target Reduced by Analyst | TIL Stock News - GuruFocus

May 22, 2025

May 22, 2025

Instil Bio Partners with ImmuneOnco for Cancer Therapy - TipRanks

May 22, 2025

May 22, 2025

Instil Bio (TIL) Advances Clinical Trials for NSCLC Treatment | TIL Stock News - GuruFocus

May 22, 2025

May 22, 2025

Alerts incorrectly tagged to T Rowe Price Large-Cap Value Fund withdrawn - marketscreener.com

May 22, 2025

May 22, 2025

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 ... - Bluefield Daily Telegraph

May 22, 2025

May 22, 2025

Instil Bio's Lung Cancer Drug Achieves 23% Response Rate in Phase 2 Trial, Major Results Expected in Late 2025 - Stock Titan

May 22, 2025

May 20, 2025

Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews

May 20, 2025

May 20, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

May 20, 2025

May 20, 2025

Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga

May 20, 2025

May 16, 2025

(TIL) Investment Analysis - news.stocktradersdaily.com

May 16, 2025

May 13, 2025

Instil (TIL) Projects Financial Stability Through 2026 | TIL Sto - GuruFocus

May 13, 2025

May 13, 2025

Instil Bio, Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 13, 2025

May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025

May 06, 2025

Trading (TIL) With Integrated Risk Controls - news.stocktradersdaily.com

May 06, 2025

May 04, 2025

TILInstil Bio, Inc. Latest Stock News & Market Updates - Stock Titan

May 04, 2025

Apr 28, 2025

Financial Metrics Check: Microbot Medical Inc (MBOT)’s Ratios for Trailing Twelve Months - DWinneX

Apr 28, 2025

Apr 28, 2025

Investor’s Toolkit: Key Ratios for Assessing Instil Bio Inc (TIL)’s Performance - DWinneX

Apr 28, 2025

Apr 28, 2025

TIL’s Stock Market Adventure: -33.05% YTD Growth Amidst Volatility - investchronicle.com

Apr 28, 2025